Please login to the form below

Not currently logged in
Email:
Password:

BIO

This page shows the latest BIO news and features for those working in and with pharma, biotech and healthcare.

CAR-Ts take centre stage as ASH18 comes to a close

CAR-Ts take centre stage as ASH18 comes to a close

LCAR-B38M, including  an 88% overall response rate among a group of 57 patients that analysts suggest seems to hold up well against data presented by Bluebird Bio for its

Latest news

More from news
Approximately 10 fully matching, plus 161 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 26 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • Random42 exhibiting at BIO-Europe 2018

    BIO-Europe attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts. ... For more information

  • A4P Bio Consulting Ltd

    A4P Bio Consulting Ltd.

  • Combination therapies in oncology: The benefits of integrated insights

    referencing their experience in oncology, demonstrate how integrated insights from payers, KOLs, community oncologists and patients can help support bio-pharma companies with oncology assets in all stages of clinical development.

  • The Biosimilar Challenge

    The ‘biosimilar challenge’ (or ‘bio battle’) is one of the most significant commercial changes we have seen in the pharma industry.

  • emotive. expands client services team

    Alongside his role at emotive. Rob is currently studying for an MSc in Bio-business at Birkbeck, University of London, with a focus on entrepreneurship in the bio-industry. .

More from PMHub
Approximately 2 fully matching, plus 25 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics